tiprankstipranks
BiomX (PHGE)
NYSE MKT:PHGE
US Market

BiomX (PHGE) Income Statement

380 Followers

BiomX Income Statement

Last quarter (Q2 2023), BiomX's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, BiomX's net income was $-6.41M. See BiomX’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Jun 19
Total Revenue
---$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 11.97M$ 27.22M$ 35.46M$ 30.26M$ 22.21M$ 404.52K
Operating Income
$ -11.97M$ -27.22M$ -35.46M$ -30.26M$ -22.21M$ -404.52K
Net Non Operating Interest Income Expense
$ -1.02M$ -2.07M$ -699.00K$ 634.00K$ 1.16M$ 892.95K
Other Income Expense
$ -223.00K$ -1.04M$ -2.00K$ -462.00K$ 483.00K$ -5.82K
Pretax Income
$ -25.38M$ -28.25M$ -36.16M$ -30.09M$ -20.56M$ 482.60K
Tax Provision
$ 49.00K$ 65.00K$ 67.00K$ 0.00$ 0.00$ 135.20K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -12.72M$ -28.32M$ -36.23M$ -30.09M$ -20.56M$ 347.41K
Basic EPS
$ 0.29$ 0.95$ 1.39$ -1.30$ -3.66$ 0.15
Diluted EPS
$ 0.79$ 0.95$ 1.39$ -1.30$ -3.66$ 0.15
Basic Average Shares
$ 143.44M$ 29.85M$ 26.01M$ 23.06M$ 5.62M$ 2.00M
Diluted Average Shares
$ 143.44M$ 29.85M$ 26.01M$ 23.06M$ 5.62M$ 2.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---$ 262.00K$ 479.00K-
Total Expenses
$ 11.97M$ 27.22M$ 35.46M$ 30.26M$ 22.21M$ 404.52K
Net Income From Continuing And Discontinued Operation
$ -25.44M$ -28.32M$ -36.23M$ -30.09M$ -20.56M$ 347.41K
Normalized Income
$ -6.78M--$ -29.62M$ -21.05M$ 351.60K
Interest Expense
$ 555.00K--$ 0.00--
EBIT
$ -24.08M$ -26.18M$ -35.46M$ -30.09M$ -22.21M$ -404.52K
EBITDA
$ -22.30M$ -23.20M$ -32.71M$ -27.91M$ -21.89M$ -404.52K
Currency in USD

BiomX Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis